Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
European operations' revenue grew 58.4% to Rs 599.7 crore
The collaboration brings a seamless digital experience to more formulators worldwide
Rocuronium Bromide Injection had estimated annual sales of USD 54 million in the US (IQVIA MAT August 2023).
This product will be manufactured at Lupin’s Pithampur facility in India
This product will be manufactured at Lupin's Nagpur facility in India
The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
Lupin enters into BTA with Lupin Manufacturing Solutions
Tolvaptan Tablets (RLD Jynarque) had estimated annual sales of USD 287 million in the U.S. (IQVIA MAT August 2023)
Subscribe To Our Newsletter & Stay Updated
